LightMix Ebola Zaire Test Gets Approval from US FDA

by Dr. Trupti Shirole on  December 30, 2014 at 11:21 AM Drug News
RSS Email Print This Page Comment
Font : A-A+

The Swiss pharmaceutical firm Roche has received an emergency authorization from the US Food and Drug Administration (US FDA) for LightMix Ebola Zaire test for emergency use on patients with signs and symptoms of the deadly virus.
 LightMix Ebola Zaire Test Gets Approval from US FDA
LightMix Ebola Zaire Test Gets Approval from US FDA

Mobile laboratories in Guinea, Sierra Leone and Liberia currently use expensive and time-consuming tests that can take up to six hours. However, the new test can take as little as three hours.

The Ebola test, manufactured by German company TIB MOLBIOL GmbH, has also been given the European CE mark indicating it abides with the EU regulations.

Chief operations officer of Roche's diagnostics division, Roland Diggelmann said, "The LightMix Ebola Zaire test is an easy-to-use molecular diagnostic test providing a solution for healthcare professionals to quickly detect the virus and start patient treatment as early as possible."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Varicocele Congo Fever Testicle Pain - Symptom Evaluation Ebola Virus Disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive